79 related items for PubMed ID: 7478121
1. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and influence of proteinuria.
Kamper AL, Strandgaard S, Leyssac PP.
Nephrol Dial Transplant; 1995; 10(7):1182-8. PubMed ID: 7478121
[Abstract] [Full Text] [Related]
2. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z, Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[Abstract] [Full Text] [Related]
3. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Ruggenenti P, Perna A, Mosconi L, Matalone M, Pisoni R, Gaspari F, Remuzzi G.
Kidney Int Suppl; 1997 Dec; 63():S54-7. PubMed ID: 9407422
[Abstract] [Full Text] [Related]
4. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ, Petersen JR, Talleruphuus U, Møller ML, Ladefoged SD, Mehlsen J, Jensen HA.
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[Abstract] [Full Text] [Related]
5. [Angiotensin I converting enzyme inhibitor enalapril in treatment of progressive chronic nephropathy. An open randomized controlled trial].
Kamper AL, Strandgaard S, Leyssac PP.
Ugeskr Laeger; 1993 Aug 02; 155(31):2406-9. PubMed ID: 8346593
[Abstract] [Full Text] [Related]
6. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG, Apperloo AJ, Rensma PL, Stegeman CA, Sluiter WJ, de Zeeuw D, de Jong PE.
Kidney Int Suppl; 1997 Dec 02; 63():S58-62. PubMed ID: 9407423
[Abstract] [Full Text] [Related]
7. Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz HE, Wiegmann TB, Cnaan A, Shahinfar S, Sica DA, Broadstone V, Schwartz SL, Mengel MC, Segal R, Versaggi JA.
Kidney Int Suppl; 1994 Feb 02; 45():S150-5. PubMed ID: 8158885
[Abstract] [Full Text] [Related]
8. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
[Abstract] [Full Text] [Related]
9. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM, Aboudara MC, Uy AL, Olson SW, Cushner HM, Yuan CM.
Am J Kidney Dis; 2009 Apr 25; 53(4):606-16. PubMed ID: 19216016
[Abstract] [Full Text] [Related]
10. Long-term effect of a chicken-based diet versus enalapril on albuminuria in type 2 diabetic patients with microalbuminuria.
de Mello VD, Zelmanovitz T, Azevedo MJ, de Paula TP, Gross JL.
J Ren Nutr; 2008 Sep 25; 18(5):440-7. PubMed ID: 18721739
[Abstract] [Full Text] [Related]
11. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
Ruilope LM, Aldigier JC, Ponticelli C, Oddou-Stock P, Botteri F, Mann JF.
J Hypertens; 2000 Jan 25; 18(1):89-95. PubMed ID: 10678548
[Abstract] [Full Text] [Related]
12. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S, Mahajan SK, Sen R, Sharma A.
J Assoc Physicians India; 2002 Oct 25; 50():1245-9. PubMed ID: 12568207
[Abstract] [Full Text] [Related]
13. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
Cruzado JM, Poveda R, Ibernón M, Díaz M, Fulladosa X, Carrera M, Torras J, Bestard O, Navarro I, Ballarín J, Romero R, Grinyó JM.
Nephrol Dial Transplant; 2011 Nov 25; 26(11):3596-602. PubMed ID: 21393611
[Abstract] [Full Text] [Related]
14. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
Am J Kidney Dis; 2009 Jan 25; 53(1):26-32. PubMed ID: 18930568
[Abstract] [Full Text] [Related]
15. The influence of angiotensin-converting enzyme inhibition on renal tubular function in progressive chronic nephropathy.
Kamper AL, Holstein-Rathlou NH, Leyssac PP, Strandgaard S.
Am J Kidney Dis; 1996 Dec 25; 28(6):822-31. PubMed ID: 8957033
[Abstract] [Full Text] [Related]
16. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH, Baggen RG, Pauli S, Lindemans A, Vulto AG, Poldermans D, Boomsma F.
J Hypertens; 2006 Nov 25; 24(11):2285-92. PubMed ID: 17053552
[Abstract] [Full Text] [Related]
17. Angiotensin converting enzyme inhibitor and chronic renal failure.
Sitprija V, Lumlertgul D.
J Med Assoc Thai; 1993 Jul 25; 76(7):359-67. PubMed ID: 8089635
[Abstract] [Full Text] [Related]
18. Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial.
Elung-Jensen T, Heisterberg J, Sonne J, Strandgaard S, Kamper AL.
Eur J Clin Pharmacol; 2005 Apr 25; 61(2):87-96. PubMed ID: 15761754
[Abstract] [Full Text] [Related]
19. Enalapril in the treatment of hypertension associated with renal failure: results from a multicenter study.
Mioli V, Boggi R, Greco A, Capponi E, Trivelli G, Cecchini F, Acciarri PM, Concetti M, Panichi N, Radicioni R.
Riv Eur Sci Med Farmacol; 1990 Apr 25; 12(2):127-34. PubMed ID: 2080310
[Abstract] [Full Text] [Related]
20. Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.
Kamper AL, Nielsen OJ.
Scand J Clin Lab Invest; 1990 Oct 25; 50(6):611-8. PubMed ID: 2247767
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
